Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.12968/hmed.2013.74.6.353 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Epidemiological Analysis of Respiratory Diseases in Mexico From 2000 to 2020: Trends, Geographic Distribution, and Public Health Challenges.
Cureus
December 2024
Faculty of Biology, Autonomous University of Sinaloa, Culiacan, MEX.
Introduction: In Mexico, respiratory diseases such as tuberculosis (TB), acute respiratory infections (ARI), pertussis (Pt), and pneumonia-bronchopneumonia (Nemu) represent critical public health challenges that contribute to morbidity and mortality and are exacerbated by socioeconomic factors and the COVID-19 pandemic.
Objective: To evaluate the trends, seasonal patterns, and geographic distribution of major respiratory diseases in Mexico between 2000 and 2020.
Methodology: Data from the National Epidemiologic Surveillance System were analyzed using advanced statistical methods, including Kruskal-Wallis tests, Mann-Whitney analysis, and multivariate analysis, to identify temporal and regional variations.
spondylitis in an immunocompetent patient with annular high signal around the intervertebral disks: a case report and literature review.
Front Med (Lausanne)
January 2025
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
spondylitis is a rare fungal infection, primarily occurring in immunocompromised patients, although cases in immunocompetent individuals have also been reported. While is commonly associated with pulmonary infections, it can also cause spondylitis. Patients typically present with back pain, limb numbness, and neurological compression symptoms.
View Article and Find Full Text PDFPopulation-Based Analysis of the Risk of Mycobacterial Infections Associated With Immune Checkpoint Inhibitors.
Clin Infect Dis
January 2025
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
In this population-based study, we examined the risk of nontuberculous mycobacterial disease associated with immune checkpoint inhibitors among people with cancer. Using a nested case-control design, we identified 184 cases and 714 matched controls; there was no significant association on conditional logistic regression (adjusted odds ratio, 0.51 [95% confidence interval, .
View Article and Find Full Text PDFPortuguese consensus on first line treatment of moderate-to-severe psoriasis with a non-TNF inhibitor therapy - a delphi methodology.
J Dermatolog Treat
December 2025
Dermatology Department, Hospital de S. José, Unidade Local de Saúde São José, Lisboa, Portugal.
Introduction: Psoriasis (PsO) is a common chronic, inflammatory, immune-mediated disease. In 2023, a 4.4% prevalence of PsO was reported in Portugal.
View Article and Find Full Text PDFIncidence of adverse drug reactions among tuberculosis patients initiated on daily drug regimen in a southern district of Karnataka.
Perspect Clin Res
August 2024
Centre for Digital Health, Artificial Intelligence, Research and Training, Basaweshwara Medical College and Hospital, Chitradurga, Karnataka, India.
Aim: The study aimed to determine the incidence of adverse drug reactions (ADRs) among newly diagnosed tuberculosis (TB) patients receiving daily drug regimen with fixed-dose combination treatment under the National Tuberculosis Elimination Program.
Materials And Methods: A community-based prospective cohort study was carried out in the Udupi district. Over 12 months, all newly diagnosed TB patients of either gender were included from 63 primary health centers and 6 community health centers, and ADRs were recorded by personal interviews.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!